CME webinar: Heart Failure – Targeted Optimal Pharmacotherapy

Aug. 2024Education/Webinars

Please join us for a live, CME-accredited webinar on Wednesday, Oct. 30, from noon to 1 p.m. that will review targeted optimal pharmacotherapy in patients with heart failure.

At the end of this learning session, you will be able to:

  • Describe the pathophysiology and the physiological effects of key medication classes for heart failure.
  • Define the revisions in heart failure classification and guideline-directed medical therapy (GDMT) per the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure.
    • HFrEF (Quadruple therapy as the standard of care)
    • HFimpF
    • HFmrEF
    • HFpEF
  • Identify the risk and management of heart failure in people with diabetes.
  • Recognize the clinical benefits of GDMT for heart failure and the opportunities for improvement.
  • Describe the UPMC Health Plan GDMT heart failure initiative and clinical outcomes.

Presenters:

  • Nick DeGregorio, MD, MMM, FACP, AVP, Medicaid Services, UPMC Health Plan
  • Melinda Morgan, PharmD, Manager, Clinical Pharmacy, UPMC Health Plan

Register now. This webinar will be recorded.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. The maximum number of hours awarded for this Continuing Pharmacy Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.


Recent Announcements

Voluntary nationwide recall: Sucralfate (Nostrum – July)

Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.
Jul. 2025Pharmacy Updates

Receive consultations to better support the behavioral health needs of child and adolescent patients

The Telephonic Psychiatric Consultation Service Program (TiPS) is a Pennsylvania HealthChoices program that gives primary care providers access to free, on-demand consultations with child and adolescent psychiatrists, typically within 30 minutes. It is available to providers of children and adolescents who have Pennsylvania Medicaid, Children’s Health Insurance Program, or UPMC Health Plan commercial insurance.
Jul. 2025What's New

Voluntary nationwide recall: Sucralfate (Nostrum – July)

Nostrum Laboratories, Inc. is recalling all lots of Sucralfate Tablets USP 1 gram. Sucralfate is used for the prevention and treatment of certain stomach ulcers.
Jul. 2025Pharmacy Updates